Abstract
Patients with type 2 diabetes mellitus (T2D) are prone to micro- and macro-vascular complications. Monomeric and oligomeric flavanols (MOF) isolated from grape seeds (Vitis vinifera) have been linked to improved endothelial function and vascular health. The aim of this study is to determine the effect of a daily supplementation of 200 mg MOF on renal endothelial function of patients with T2D and microalbuminuria. For this double-blind, placebo-controlled, randomized, multicenter trial 96 individuals (ages 40-85 years) with T2D and microalbuminuria will be recruited. Participants will be randomly assigned to the intervention group, receiving 200 mg of MOF daily for 3 months, or to the control group, receiving a placebo. The primary endpoint is the evolution over time in albumin excretion rate (AER) until 3 months of intervention as compared with placebo. Secondary endpoints are the evolution over time in established plasma markers of renal endothelial function-asymmetric dimethylarginine (ADMA), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular cell adhesion molecule-1 (sICAM-1), interleukin-6 (IL-6), and von Willebrand Factor (vWF)-until 3 months of intervention as compared with placebo. Mixed modeling ...Continue Reading
References
Nov 1, 1995·The American Journal of Medicine·L M LaffelD J Gans
Aug 1, 1995·Diabetes Research and Clinical Practice·R C Turner, R R Holman
Aug 1, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·K G Alberti, P Z Zimmet
Jun 13, 2001·Circulation·J E FreedmanJ D Folts
Oct 6, 2001·Diabetologia·E T LeeM Lu
Dec 11, 2002·Kidney International·Amanda I AdlerUNKNOWN UKPDS GROUP
Jan 7, 2005·Molecular Nutrition & Food Research·Salka Elbøl RasmussenLea Poulsen
Jul 16, 2005·European Journal of Clinical Pharmacology·Roberto FogariPaola Preti
Jun 24, 2006·Journal of Cardiovascular Pharmacology·Peter OchodnickyDick de Zeeuw
Aug 4, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·P KarM Cummings
Feb 6, 2010·Health and Quality of Life Outcomes·Oddvar SolliI S Kristiansen
Jul 19, 2011·Atherosclerosis·R S RosensonP M Dodson
Aug 2, 2011·Journal of the American Dietetic Association·Harm H H FeringaCraig I Coleman
Sep 15, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M E HellemonsM Rudnicki
Dec 17, 2011·PloS One·Antje R WeselerAalt Bast
Dec 18, 2013·The British Journal of Nutrition·Anna VogiatzoglouGunter G C Kuhnle
Dec 18, 2013·The Journal of Nutrition·Amy JenningsAedín Cassidy
Dec 26, 2013·The Journal of Nutrition·Raul Zamora-RosNicholas J Wareham
Feb 21, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A Tresserra-RimbauUNKNOWN PREDIMED Study Investigators
Mar 1, 2014·Diabetes Care·Juuso I BlomsterGraham S Hillis
Apr 26, 2014·PloS One·Dragan MilenkovicAntje R Weseler
May 7, 2015·The Lancet. Diabetes & Endocrinology·Marcel H A MuskietDaniël H van Raalte
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association